Skip to main content
Premium Trial:

Request an Annual Quote

Dutch Medical Center to Use Oracle's Infrastructure for Personalized Medicine Research

Premium

NEW YORK (GenomeWeb) – Oracle said this week that Erasmus University Medical Center Rotterdam has selected the Oracle Health Sciences Translational Research Center and the Oracle Exadata Database Machine to support research projects focused on personalized medicine and better patient outcomes.

Erasmus chose its solution because of its ability to simultaneously query clinical and omics data, which "will be vital to advancing our next-generational genomics research initiatives," Jan Hazelzet, Erasmus' chief medical information officer, said in a statement. "As we expand the deployment across our enterprise, the platform's centralized data warehouse will enable in-depth analysis of patient outcomes and cost of care from a single source."

Oracle said that Erasmus will use the solution to analyze clinical and omics data to identify new biomarkers that could help clinicians make more personalized treatment recommendations. Erasmus' first project on the Oracle platform will focus on improving care and outcomes for patients with craniofacial malformations. The initiative will involve performing whole genome sequencing on over 1,000 patients, according to Oracle. Erasmus will also use the platform to explore the cost-effectiveness of specific treatments.

Financial and other terms of the agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.